IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $584,862 | +129.9% | 128,541 | +208.8% | 0.00% | 0.0% |
| Q1 2023 | $254,372 | -92.8% | 41,632 | -88.7% | 0.00% | -94.4% |
| Q3 2022 | $3,528,000 | +882.7% | 368,310 | +1609.4% | 0.02% | +800.0% |
| Q1 2022 | $359,000 | -84.8% | 21,546 | -82.6% | 0.00% | -66.7% |
| Q4 2021 | $2,359,000 | +128.1% | 123,591 | +194.5% | 0.01% | +100.0% |
| Q3 2021 | $1,034,000 | +23.2% | 41,961 | +30.2% | 0.00% | 0.0% |
| Q2 2021 | $839,000 | -41.5% | 32,234 | -28.9% | 0.00% | -66.7% |
| Q1 2021 | $1,435,000 | +245.0% | 45,327 | +258.6% | 0.01% | +50.0% |
| Q3 2020 | $416,000 | -88.5% | 12,640 | -90.4% | 0.01% | -89.8% |
| Q2 2020 | $3,617,000 | +1673.0% | 131,770 | +1834.9% | 0.06% | +1080.0% |
| Q1 2020 | $204,000 | -85.4% | 6,810 | -86.5% | 0.01% | -37.5% |
| Q4 2019 | $1,393,000 | +120.4% | 50,320 | +44.9% | 0.01% | +33.3% |
| Q3 2019 | $632,000 | -52.7% | 34,728 | -36.3% | 0.01% | -53.8% |
| Q2 2019 | $1,337,000 | -58.2% | 54,515 | -83.8% | 0.01% | -61.8% |
| Q1 2019 | $3,201,000 | +67.1% | 336,627 | +55.5% | 0.03% | +54.5% |
| Q4 2018 | $1,916,000 | -32.7% | 216,452 | -14.4% | 0.02% | -35.3% |
| Q3 2018 | $2,846,000 | +54.4% | 253,000 | +75.7% | 0.03% | +41.7% |
| Q2 2018 | $1,843,000 | +2.4% | 144,000 | +35.2% | 0.02% | -17.2% |
| Q1 2018 | $1,800,000 | +1507.1% | 106,500 | +663.7% | 0.03% | +1350.0% |
| Q4 2017 | $112,000 | -66.6% | 13,946 | -67.7% | 0.00% | -66.7% |
| Q3 2017 | $335,000 | – | 43,206 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |